Login
$LAES
$1.62 +$0.10 (6.58%) Live

$LAES 4 SEC Filings

Filed On Filing
07 Oct 2026 Form 4: Enguent Jean-Pierre, Vice President, R&DSS

Received 35,000 shares by exercise or conversion ($350) · Granted 50,000 Employee Stock Option Plan (right to buy) · Sold 35,000 shares ($85.9K)

06 Oct 2026 Form 4: Fergusson David Alexander, Director

Granted 17,487 Employee Stock Option Plan (right to buy)

06 Oct 2026 Form 4: Pellaton Eric Adrien, Director

Granted 24,810 Employee Stock Option Plan (right to buy)

06 Oct 2026 Form 4: Ward Peter, Director

Granted 8,268 Employee Stock Option Plan (right to buy)

03 Sep 2026 Form 4: Enguent Jean-Pierre, Vice President, R&DSS

Received 15,000 shares by exercise or conversion ($150) · Sold 15,000 shares ($36K)

05 Aug 2026 Form 4: Enguent Jean-Pierre, Vice President, R&DSS

Received 15,000 shares by exercise or conversion ($150) · Sold 15,000 shares ($36.9K)

08 Jul 2026 Form 4: Enguent Jean-Pierre, Vice President, R&DSS

Received 15,000 shares by exercise or conversion ($150) · Sold 15,000 shares ($42.3K)

18 Jun 2026 Form 4: Ward Peter, Director

Received 366,746 shares by exercise or conversion ($3.67K) · Gave up 96,530 shares to cover exercise price or tax ($296K)

05 Jun 2026 Form 4: Moreira Carlos, Director

Sold 300 shares ($1.05K)

05 Jun 2026 Form 4: O'Hara John Charles, Director

Sold 143 shares ($502)

03 Jun 2026 Form 4: O'Hara John Charles, Director

Sold 10,000 shares ($36.9K) · Sold 5,582 shares ($19.7K)

03 Jun 2026 Form 4: Moreira Carlos, Director

Sold 10,000 shares ($36.9K) · Sold 7,005 shares ($24.7K)

03 Jun 2026 Form 4: Enguent Jean-Pierre, Vice President, R&DSS

Received 15,000 shares by exercise or conversion ($150) · Granted 60,000 Employee Stock Option Plan (right to buy) · Sold 15,000 shares ($52.7K)

29 May 2026 Form 4: Moreira Carlos, Director

Sold 4,139 shares ($14.5K) · Sold 10,000 shares ($35.1K)

29 May 2026 Form 4: O'Hara John Charles, Director

Sold 4,689 shares ($16.4K) · Sold 10,000 shares ($35.1K)

15 May 2026 Form 4: Buonanno Franck Jean, Vice-President, Global Sales

Sold 20,000 shares ($58K)

11 May 2026 Form 4: Buonanno Franck Jean, Vice-President, Global Sales

Received 20,000 shares by exercise or conversion ($200)

07 May 2026 Form 4: Enguent Jean-Pierre, Vice President, R&DSS

Sold 15,000 shares ($47K)

04 May 2026 Form 4: Enguent Jean-Pierre, Vice President, R&DSS

Received 15,000 shares by exercise or conversion ($150)

24 Apr 2026 Form 4: O'Hara John Charles, Director

Sold 10,000 shares ($30.6K) · Sold 10,000 shares ($28.8K) · Sold 5,250 shares ($15.3K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support